493 related articles for article (PubMed ID: 29654337)
1. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening.
Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C
Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337
[TBL] [Abstract][Full Text] [Related]
2. Fast recognition of trace volatile compounds with a nanoporous dyes-based colorimetric sensor array.
Wang Y; Zhong X; Huo D; Zhao Y; Geng X; Fa H; Luo X; Yang M; Hou C
Talanta; 2019 Jan; 192():407-417. PubMed ID: 30348411
[TBL] [Abstract][Full Text] [Related]
3. Detecting cancer by breath volatile organic compound analysis: a review of array-based sensors.
Queralto N; Berliner AN; Goldsmith B; Martino R; Rhodes P; Lim SH
J Breath Res; 2014 Jun; 8(2):027112. PubMed ID: 24862241
[TBL] [Abstract][Full Text] [Related]
4. Progress in the development of volatile exhaled breath signatures of lung cancer.
Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
[TBL] [Abstract][Full Text] [Related]
5. A novel device based on a fluorescent cross-responsive sensor array for detecting lung cancer related volatile organic compounds.
Lei JC; Hou CJ; Huo DQ; Luo XG; Bao MZ; Li X; Yang M; Fa HB
Rev Sci Instrum; 2015 Feb; 86(2):025106. PubMed ID: 25725887
[TBL] [Abstract][Full Text] [Related]
6. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE
IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482
[TBL] [Abstract][Full Text] [Related]
7. Chemiresistive Sensor Array with Nanostructured Interfaces for Detection of Human Breaths with Simulated Lung Cancer Breath VOCs.
Shang G; Dinh D; Mercer T; Yan S; Wang S; Malaei B; Luo J; Lu S; Zhong CJ
ACS Sens; 2023 Mar; 8(3):1328-1338. PubMed ID: 36883832
[TBL] [Abstract][Full Text] [Related]
8. Prospects and Challenges of Volatile Organic Compound Sensors in Human Healthcare.
Jalal AH; Alam F; Roychoudhury S; Umasankar Y; Pala N; Bhansali S
ACS Sens; 2018 Jul; 3(7):1246-1263. PubMed ID: 29879839
[TBL] [Abstract][Full Text] [Related]
9. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
10. Volatile signature for the early diagnosis of lung cancer.
Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
[TBL] [Abstract][Full Text] [Related]
11. Advances in the early detection of lung cancer using analysis of volatile organic compounds: from imaging to sensors.
Li W; Liu HY; Jia ZR; Qiao PP; Pi XT; Chen J; Deng LH
Asian Pac J Cancer Prev; 2014; 15(11):4377-84. PubMed ID: 24969857
[TBL] [Abstract][Full Text] [Related]
12. Colorimetric sensor arrays for volatile organic compounds.
Janzen MC; Ponder JB; Bailey DP; Ingison CK; Suslick KS
Anal Chem; 2006 Jun; 78(11):3591-600. PubMed ID: 16737212
[TBL] [Abstract][Full Text] [Related]
13. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
[TBL] [Abstract][Full Text] [Related]
14. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
15. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
Oakley-Girvan I; Davis SW
Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
[TBL] [Abstract][Full Text] [Related]
16. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis.
Sun X; Shao K; Wang T
Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028
[TBL] [Abstract][Full Text] [Related]
17. Exhaled breath biopsy: a new cancer detection paradigm.
Abderrahman B
Future Oncol; 2019 May; 15(15):1679-1682. PubMed ID: 30977676
[No Abstract] [Full Text] [Related]
18. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
19. VOC biomarkers identification and predictive model construction for lung cancer based on exhaled breath analysis: research protocol for an exploratory study.
Li W; Dai W; Liu M; Long Y; Wang C; Xie S; Liu Y; Zhang Y; Shi Q; Peng X; Liu Y; Li Q; Duan Y
BMJ Open; 2019 Aug; 9(8):e028448. PubMed ID: 31399453
[TBL] [Abstract][Full Text] [Related]
20. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
